Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00641_DB04855_nanopub.RA2Rp-OY0xvDyIBpY3uJzd9CYRyV1508_yiGy8mEoaiHA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00641_DB04855 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00641_DB04855 label "DDI between Simvastatin and Dronedarone - Dronedarone is a CYP2D6 inhibitor thus increasing serum concentrations of simvastatin 4-fold. Lower doses of simvastatin and doses should not exceed 20 mg to avoid statin-induced toxicities like myopathy. Consider rosuvastatin as cholesterol lowering therapy as there is no significant interaction between rosuvastatin and dronedarone. [drugbank_resource:DB00641_DB04855]" assertion.
- drugbank_resource:DB00641_DB04855 identifier "drugbank_resource:DB00641_DB04855" assertion.
- drugbank_resource:DB00641_DB04855 title "DDI between Simvastatin and Dronedarone - Dronedarone is a CYP2D6 inhibitor thus increasing serum concentrations of simvastatin 4-fold. Lower doses of simvastatin and doses should not exceed 20 mg to avoid statin-induced toxicities like myopathy. Consider rosuvastatin as cholesterol lowering therapy as there is no significant interaction between rosuvastatin and dronedarone." assertion.
- drugbank:DB00641 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00641_DB04855 assertion.
- drugbank:DB04855 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00641_DB04855 assertion.